Publication | Open Access

Design, synthesis, and pharmacological evaluation of multitarget-directed ligands with both serotonergic subtype 4 receptor (5-HT4R) partial agonist and 5-HT6R antagonist activities, as potential treatment of Alzheimer’s disease

Neurodegenerative DiseasesAlzheimer's DiseaseMedicineNeurotransmitterMultitarget-directed LigandsSerotonergic Subtype 4NeuropharmacologyNeuroscienceNeurologyPharmacologyNeurochemistryPartial AgonistDrug Discovery